Watchlist Price Alert

MiNK Therapeutics Inc. (INKT)

NASDAQ: INKT · Real-Time Price · USD

7.60

0.20 (2.70%)

At close: May 02, 2025, 3:48 PM

7.96

4.74%

After-hours: May 02, 2025, 04:05 PM EDT

MiNK Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	4.58M	6.33M	9.31M	5.82M	3.37M	6.4M	10.62M	14.89M	19.64M	24.16M	29.85M	34.69M	38.89M	819.45K	1.66M	-2.69M	2.69M	-299.04K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.38M	n/a	598.07K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-1	0.00	-0.00	-0.00	-0.00	-0.00	-0.00	n/a	n/a	n/a	n/a	-2.69M	n/a	-299.04K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	23K	35K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.76K	2.58M	2.23M	n/a	1.03M	n/a
Other Current Assets	164.24K	11.2K	61.14K	122.48K	177.96K	29.34K	166.03K	320.89K	470.3K	37.52K	378.13K	604.64K	721.32K	2.57M	2.37M	n/a	913.58K	n/a
Total Current Assets	4.99M	6.58M	9.47M	6M	3.6M	6.47M	11.05M	15.52M	20.4M	24.46M	30.33M	35.48M	39.63M	3.44M	4.2M	2.69M	4.1M	299.04K
Property-Plant & Equipment	732.93K	799.52K	849.96K	894.99K	953.98K	991.46K	1.06M	1.07M	1.07M	803.13K	787.54K	665.21K	606.6K	635.89K	552.48K	n/a	458.38K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	732.93K	799.52K	849.96K	894.99K	953.98K	991.46K	1.06M	1.07M	1.07M	803.13K	787.54K	665.21K	606.6K	635.89K	552.48K	-2.69M	458.38K	-299.04K
Total Assets	5.72M	7.37M	10.32M	6.89M	4.55M	7.46M	12.11M	16.59M	21.47M	25.26M	31.12M	36.14M	40.24M	4.08M	4.75M	n/a	4.56M	n/a
Account Payables	2.73M	2.36M	3.2M	3.49M	3.91M	4.28M	4.89M	6M	5.82M	5.17M	4.79M	3.73M	3M	1.65M	2.27M	n/a	3.14M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.11M	7.24M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	65.42M	52.53M	n/a	n/a	n/a
Other Current Liabilities	2.36M	5.04M	6.94M	2.34M	5.66M	2.27M	2.33M	2.49M	5.21M	10.44M	9.79M	12.45M	12.89M	10.4M	10.3M	n/a	9.22M	n/a
Total Current Liabilities	6.96M	7.4M	10.15M	11.11M	11.4M	10.39M	11.46M	11.25M	12.68M	18.45M	17.43M	18.83M	16.47M	80.56M	67.55M	n/a	14.22M	n/a
Long-Term Debt	4.92M	4.61M	4.41M	4.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	43.82M	n/a
Other Long-Term Liabilities	13.42M	12.92M	12.35M	11.87M	11.21M	10.65M	10.14M	9.81M	9.19M	58.28K	n/a	n/a	n/a	27.54K	383.06K	n/a	383.06K	n/a
Total Long-Term Liabilities	18.35M	17.53M	16.75M	16.08M	11.21M	10.65M	10.14M	9.81M	9.19M	58.28K	4.79M	3.73M	3M	27.54K	383.06K	n/a	44.21M	n/a
Total Liabilities	25.31M	24.93M	26.9M	27.19M	22.61M	21.04M	21.61M	21.06M	21.87M	18.51M	17.43M	18.83M	16.47M	80.59M	67.93M	n/a	58.43M	n/a
Total Debt	4.92M	4.61M	4.41M	4.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	65.42M	52.53M	n/a	43.82M	n/a
Common Stock	40.00	395.00	394.00	347.00	346.00	345.00	345.00	343.00	339.00	338.00	337.00	336.00	335.00	242.00	242.00	n/a	242.00	n/a
Retained Earnings	-144.18M	-141.72B	-139.91M	-137.21M	-133.4M	-127.94M	-122.82M	-116.63M	-110.94M	-103.17M	-96.84M	-90.72M	-82.95M	-77.18M	-62.92M	n/a	-52.74M	n/a
Comprehensive Income	-631.58K	-672.84M	-611.38K	-385.78K	-430.95K	-313.19K	-401.81K	-373.8K	-292.47K	-78.28K	1.3M	-102.5K	-625.27K	-789.34K	-1.34M	-53.87M	-1.52M	-36.33M
Shareholders Equity	-19.59M	-17.55M	-16.58M	-20.3M	-18.06M	-13.58M	-9.5M	-4.48M	-401.3K	6.76M	13.69M	17.31M	23.78M	-76.51M	-63.18M	-53.87M	-53.87M	-36.33M
Total Investments	n/a	6.32B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.38M	n/a	598.07K